Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Testing the world’s first gene therapy for hearing loss

      Researchers in America have started a clinical trial to test a ground breaking gene therapy which aims to treat hearing loss by restoring sound detecting cells that have been damaged by trauma to the inner ear. Nicola Robas, from our Biomedical Research team, tells us more about this exciting research

      By: Nicola Robas | 05 January 2015

      Hearing Loss caused by damage to the inner ear hair cells

      When sound enters the ear, it is detected by cells in the inner ear called hair cells.  These hair cells (so-called because of the tiny hair-like projections on their surface) are vital to our ability to hear as they convert the pitch and loudness of sound into an electrical signal which is then sent to the brain.  Hair cells can be lost during aging and damaged by trauma to the ear such as loud noises and toxic drugs.  Following birth, all mammals lose the ability to regenerate hair cells meaning that any damage can lead to a permanent hearing loss.  Interestingly birds and amphibians retain the ability to regenerate hair cells throughout their lives. These observations have led to a lot of research into how these regenerative pathways work and how they could be safely activated in people in order to “regrow” lost hair cells and restore hearing.

      The “Atoh1 switch”

      About 10 years ago a gene called Atoh1 was discovered which acts as a “switch” to turn on hair cell growth. In mammals the Atoh1 switch is turned off following birth but in birds and amphibians it remains on into adulthood. It was discovered that when Atoh1 is artificially switched on in the cells that support hair cells (called “supporting cells”) it instructs them to divide and form new hair cells.  This led researchers to investigate whether Atoh1 could be used as a gene therapy to treat certain types of profound hearing loss.

      What is gene therapy?

      Gene therapy is the introduction of a gene into the human body in order to treat a disease or condition. Gene therapy can be used to replace a faulty gene with a normal copy or activate a gene that has been switched-off. One way of introducing a gene is by incorporating it to a harmless virus which “infects” the appropriate cells and delivers copies of the therapeutic gene. Once inside the cell, the gene is switched on and is able to have its biological effect. A biotech company called Genvec has developed a gene therapy (known by its experimental name CGF166) consisting of virus-delivered Atoh1. In isolated cells, the introduction of CGF166 has been shown to activate Atoh1 biological pathways and in animal models the gene was able to safely restore hearing. Clinical researchers now want to test if CGF166 will have the same beneficial effect in people with profound hearing loss.  

      A clinical trial to test CGF166 in people

      In partnership with Genvec, the pharmaceutical company Novartis has begun a clinical trial to test CGF166 in people for the first time.  The goal of this study is to assess whether inner ear infusion of CGF166 is safe and whether it is effective at treating hearing loss. In this first trial, researchers plan to test the therapy in about 45 people who have profound hearing loss in both ears caused by toxic side effects of medicines.  This group will have lost a large number of hair cells but will still have intact supporting cells and nerves within the ear.  The gene therapy treatment consists of a one-off 20 microlitre (0.02 millilitre) dose injected directly into the inner ear by a surgical procedure that lasts about 45 minutes. Changes in hearing will be monitored before and after treatment. This therapy would not help people with types of inherited deafness where structures in the ear needed to support new hair cell growth are missing or who have damage to the auditory nerve, but researchers believe that CGF166 could potentially benefit people who have acquired their hearing loss through drug toxicity, noise damage and aging.

      The clinical trial started in October 2014 and the results are expected in 2017.

      More information can be found at the Novartis website

      Recent Posts

      Can brain activity tell us how well a child can hear with their cochlear implants?

      Researchers in Nottingham are developing a new way to tell how well young children and babies can hear with their implant, by looking at their brain activity. We’re funding PhD student, Faizah Mushtaq, to develop a tool that could help children with cochlear implants. Faizah tells us more about her exciting research and how you can help.

      By: Faizah Mushtaq
      18 September 2018

      Detecting sound is easy - the hard bit is getting a machine to know what it means

      Whether it’s the sound of a doorbell, or complex speech patterns, sound recognition technology will transform everyone’s lives - including people with hearing loss and deafness. Kevin Taylor, our Product Technologist, tells us more.

      By: Kevin Taylor
      17 September 2018

      Treatments for hearing loss: What’s new?

      Over 20 treatments to restore or protect hearing are currently in clinical trials. If they are successful and pass all three stages of these trials, the way we manage hearing loss could change significantly. Our Translational Research Manager, Dr Carina Santos, tells us the good news.

      By: Carina Santos
      14 September 2018

      How to stay safe and independent at home

      If you, or a loved one, can’t hear the doorbell, phone, baby monitor or smoke alarm, one simple solution will offer total peace of mind. The Bellman Visit paging system will alert you to important sounds around the home so you can stay safe and independent.

      By: Sally Bromham
      06 September 2018

      Recent Posts

      Can brain activity tell us how well a child can hear with their cochlear implants?

      Researchers in Nottingham are developing a new way to tell how well young children and babies can hear with their implant, by looking at their brain activity. We’re funding PhD student, Faizah Mushtaq, to develop a tool that could help children with cochlear implants. Faizah tells us more about her exciting research and how you can help.

      By: Faizah Mushtaq
      18 September 2018

      Detecting sound is easy - the hard bit is getting a machine to know what it means

      Whether it’s the sound of a doorbell, or complex speech patterns, sound recognition technology will transform everyone’s lives - including people with hearing loss and deafness. Kevin Taylor, our Product Technologist, tells us more.

      By: Kevin Taylor
      17 September 2018

      Treatments for hearing loss: What’s new?

      Over 20 treatments to restore or protect hearing are currently in clinical trials. If they are successful and pass all three stages of these trials, the way we manage hearing loss could change significantly. Our Translational Research Manager, Dr Carina Santos, tells us the good news.

      By: Carina Santos
      14 September 2018

      How to stay safe and independent at home

      If you, or a loved one, can’t hear the doorbell, phone, baby monitor or smoke alarm, one simple solution will offer total peace of mind. The Bellman Visit paging system will alert you to important sounds around the home so you can stay safe and independent.

      By: Sally Bromham
      06 September 2018

      More like this

      As the largest charity for people with hearing loss in the UK, we understand how hearing loss can affect everything in your life from your relationships, to your education and...

      It’s Deaf Awareness Week 2018 from 14–20 May. Download and use our free posters, communication tips cards and fingerspelling cards to help increase deaf awareness in your office, school or...

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​